Macular Degeneration Clinical Trials
| Macular degeneration clinical trials help to determine what treatments are the safest and most effective for the prevention and treatment of macular degeneration. |
Macular Degeneration Research
The most current information for macular degeneration studies is easy to access.The website www.ClinicalTrials.gov is a registry of federally and privately supported studies conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's: purpose,
who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals. Just type in "macular degeneration" in the search field and a list of all the studies in 157 countries will come up. Currently there are 185 studies seeking new volunteers.
Dry Macular Degeneration Research
Dry macular degeneration research is slowly gaining progress. Although there are many more clinical trials for wet AMD, there are a couple of studies for the dry form.
To find out some of the studies that are currently available click here:
Dry Macular Degeneration Research
Wet Macular Degeneration Reearch
As of Januray 2011 there are close to 50 studies that are recruiting participants who have wet AMD.
Wet macular degeneration research may involve treatments using radiation, anti-VEGF therapies, and combinations of different therapies.
For more information on wet macular degeneration clinical trials click here:
Wet Macular Degneration Clinical Trials
Macular Degeneration Treatment
Searching macular degeneration clinical trials by treatment is also an option. Some of your searches could be: "Macular degeneration lutein"
"Macular degeneration avastin"
"Macular degeneration omega 3"
"Macular degeneration antioxidants"
Try it now by clicking on the link below:
Clinical Trials
Clinical Trial Phases
Clinical trials are categorized by phases. Their are four phases with Phase I clinical trials testing mostly for safety and toxicity.
You will find the phase listed in the Purpose section of the clinical trials in a box with these labels - Condition, Intervention and Phase.
If you are considering a clinical trial it is a good idea to know about the different phases and what phase the clinical trial is in before you agree to participate. Click here to read a detailed description:
Clinical Trial Phases
Lucentis vs Avastin Clinical Trial
Macular degeneration research is a big focus at Emory Healthcare in Atlanta. Currently Emory Eye Center is the lead center among 47 other eye institutions who are recruiting individuals with wet macular degeneration. The study will compare the two drugs that are made by the same pharmaceutical company,
Lucentis
and it's less expensive "cousin",
Avastin.
To find out if there is a study center near you click on this link:
Comparison of ARMD Treatment: Lucentis-Avastin Trial
Macular Degeneration Research - Genetics
The Jules Stein Eye Institue in Los Angeles, California is conducting a genetics study for age related macular degeneration.
This study hopes to "learn how to apply new genetic discoveries for future generations and to better counsel and develop preventive therapies for those who are at an increased risk .."
My husband and I are participating in this study even though we live in Atlanta. To find out if you or a family member are eligible for this study and what all is involved click here:
Macular Degeneration Research Genetics
Clinical Trial for Low Vision Rehab
Not all clinical trials are focused on treatment. Studies can also be looking at quality of life issues. For instance in Chicago currently there is a study in which the purpose is to measure the effectiveness of a newly designed reading rehabilitation program for patients with
dry macular disease.
Patients with wet macular degeneration are excluded from this trial. If you would like to read about this study click here:
Reading Rehabilitation
Omega 3 Research
Omega 3 research supports the intake of omega 3's for healthy eyes and a healthy macula.
One study is called the "Dietary Omega-3 Fatty Acid and Fish Intake in the Primary Prevention of Age-Related Macular Degeneration: A Systematic Review and Meta-analysis."
The authors of this study found that high dietary intake of fish oils was associated with a 38% reduction in the risk of late macular degeneration.
To learn more about how fish oil benefits the macula click here:
Omega 3 Research
For More Information:
Go from Macular Degeneration Clinical Trials to Macular Degeneration Research
Go from Macular Degeneration Clinical Trials to WebRN Macular Degeneration Home
Would you like to be updated on the latest:
√ Clinical Trials? √ Prevention of Macular Degeneration? √ Tips for Daily Living? √ Food Suggestions for a Macular Degeneration Diet? √ Ideas on Visual Aids to Maximize your Sight? If you said "yes" to any of the above, sign up for my monthly Macular Degeneration News.
New! Comments
Share your thoughts about what you just read! Leave a comment in the box below.
|